TI
Telemetry Investments Portfolio holdings
AUM
$42.8M
This Quarter Return
+1.24%
1 Year Return
-0.14%
3 Year Return
+72.15%
5 Year Return
+118.26%
10 Year Return
–
AUM
$97.3M
AUM Growth
+$97.3M
(+9.2%)
Cap. Flow
-$20.8M
Cap. Flow
% of AUM
-21.36%
Top 10 Holdings %
Top 10 Hldgs %
41.6%
Holding
158
New
47
Increased
19
Reduced
20
Closed
29
Top Buys
| 1 |
Avista
AVA
|
$3.26M |
| 2 |
KITE
Kite Pharma, Inc.
KITE
|
$3.07M |
| 3 |
ABCO
Advisory Board Co/The
ABCO
|
$2.28M |
| 4 |
Globalstar
GSAT
|
$2.25M |
| 5 |
PRXL
Parexel International Corp
PRXL
|
$2.12M |
Top Sells
| 1 |
WOOF
VCA Inc.
WOOF
|
$2.62M |
| 2 |
MBLY
Mobileye N.V.
MBLY
|
$2.26M |
| 3 |
CAB
Cabela's Inc
CAB
|
$1.93M |
| 4 |
NXP Semiconductors
NXPI
|
$1.92M |
| 5 |
PNRA
Panera Bread Co
PNRA
|
$1.83M |
Sector Composition
| 1 | Healthcare | 22.83% |
| 2 | Communication Services | 7.14% |
| 3 | Utilities | 5.01% |
| 4 | Technology | 4.98% |
| 5 | Financials | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Arbutus Biopharma
ABUS
$753M
| $682K | 0.24% |
110,000
-108,400
| -50% | -$672K |
|
|
27
NXP Semiconductors
NXPI
$57.5B
| $679K | 0.24% |
6,000
-17,000
| -74% | -$1.92M |
|
28
Fate Therapeutics
FATE
$115M
| $634K | 0.23% |
160,000
-65,700
| -29% | -$260K |
|
|
COL
29
DELISTED
Rockwell Collins
COL
| $627K | 0.22% |
+4,800
| New | +$627K |
|
|
SPA
30
DELISTED
Sparton
SPA
| $622K | 0.22% |
+26,800
| New | +$622K |
|
|
TRCO
31
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $613K | 0.22% |
15,001
+1
| +0% | +$41 |
|
32
iShares Core S&P Small-Cap ETF
IJR
$84.4B
| $594K | 0.21% |
+8,000
| New | +$594K |
|
|
PCBK
33
DELISTED
Pacific Continental Corp
PCBK
| $593K | 0.21% |
22,000
+7,000
| +47% | +$189K |
|
|
SNI
34
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $558K | 0.2% |
6,500
-3,500
| -35% | -$300K |
|
|
HSNI
35
DELISTED
HSN, Inc.
HSNI
| $547K | 0.2% |
+14,000
| New | +$547K |
|
36
Deutsche Bank
DB
$67B
| $537K | 0.19% |
+31,099
| New | +$537K |
|
37
Rigel Pharmaceuticals
RIGL
$710M
| $508K | 0.18% |
20,000
-2,000
| -9% | -$50.8K |
|
|
AKRX
38
DELISTED
Akorn, Inc.
AKRX
| $498K | 0.18% |
15,000
-1,000
| -6% | -$33.2K |
|
|
FPO
39
DELISTED
First Potomac Realty Trust
FPO
| $484K | 0.17% |
+43,431
| New | +$484K |
|
|
XCRA
40
DELISTED
Xcerra Corporation
XCRA
| $464K | 0.17% |
47,100
+2,000
| +4% | +$19.7K |
|
41
Forestar Group
FOR
$1.4B
| $439K | 0.16% |
28,025
-57,101
| -67% | -$894K |
|
42
Corvus Pharmaceuticals
CRVS
$419M
| $430K | 0.15% |
+27,000
| New | +$430K |
|
|
MTVA
43
MetaVia Inc. Common Stock
MTVA
$16.2M
| $425K | 0.15% |
8
| – | – |
|
|
FPRX
44
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $409K | 0.15% |
10,000
-22,851
| -70% | -$935K |
|
|
RXDX
45
DELISTED
Ignyta, Inc.
RXDX
| $408K | 0.15% |
33,000
-50,500
| -60% | -$624K |
|
|
AF
46
DELISTED
Astoria Financial Corporation
AF
| $389K | 0.14% |
18,100
| – | – |
|
|
SNC
47
DELISTED
State National Companies, Inc.
SNC
| $342K | 0.12% |
+16,301
| New | +$342K |
|
48
Kellanova
K
$27.5B
| $336K | 0.12% |
+5,730
| New | +$336K |
|
|
SCG
49
DELISTED
Scana
SCG
| $336K | 0.12% |
+6,931
| New | +$336K |
|
50
Oracle
ORCL
$628B
| $331K | 0.12% |
+6,840
| New | +$331K |
|